Atezolizumab and bevacizumab for hepatocellular carcinoma: How to approach salvage therapy for non-responders?: Editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”

Bibliographic Details
Main Author:	Naoshi Nishida
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2024-10-01
Series:	Clinical and Molecular Hepatology
Subjects:	hepatocellular carcinoma immune checkpoint inhibitors atezolizumab bevacizumab tyrosine kinase inhibitors clinical trials
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-0324.pdf

Internet